Research comparison
A side-by-side comparison of Semax and Selank as they are characterised in the peer-reviewed research literature. Neuropeptide CNS research. Both compounds are supplied for in-vitro laboratory research only.
| Semax | Selank | |
|---|---|---|
| Research area | Neuropeptide Research | Neuropeptide Research |
| Sizes stocked | 5mg, 10mg | 5mg, 10mg |
| Reference | Full Semax page → | Full Selank page → |
Semax is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-7) with a C-terminal Pro-Gly-Pro extension. Characterised in preclinical literature for its stability profile and effects on BDNF expression in rodent models. Supplied as lyophilised powder for in-vitro research use only.
Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin with a C-terminal Pro-Gly-Pro extension. Characterised in the literature for its effects on GABA, serotonin and dopamine signalling in preclinical models. Supplied as lyophilised powder for in-vitro research use only.
Both compounds are characterised in the research literature within neuropeptide cns research. Researchers typically consult the primary peer-reviewed publications for each compound before selecting one for a specific experimental protocol. The two are frequently studied in parallel and occasionally cited together in comparative pharmacology reviews.
Both Semax and Selank are supplied as lyophilised powder and reconstituted with bacteriostatic water using standard laboratory technique. For full reconstitution methodology see our Research Handling Guide, or compute resulting mg/ml concentrations with the Reconstitution Volume Calculator.
Every batch of both compounds is independently HPLC-verified by Janoshik Analytical at 99%+ purity. The lab report is supplied with every order and carries a unique verification key.